Research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a report released on Friday. The firm set a "hold" rating on the stock.
Milestone Scientific Trading Up 0.9 %
Shares of Milestone Scientific stock traded up $0.01 on Friday, reaching $1.09. 147,461 shares of the company were exchanged, compared to its average volume of 131,688. Milestone Scientific has a fifty-two week low of $0.58 and a fifty-two week high of $1.39. The firm has a market capitalization of $85.43 million, a price-to-earnings ratio of -15.57 and a beta of 1.12. The stock has a fifty day moving average price of $0.96 and a 200-day moving average price of $0.97.
Institutional Investors Weigh In On Milestone Scientific
Several hedge funds have recently made changes to their positions in MLSS. Geode Capital Management LLC lifted its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. Carnegie Investment Counsel raised its position in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after buying an additional 27,412 shares during the period. Renaissance Technologies LLC lifted its stake in Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock worth $121,000 after acquiring an additional 53,198 shares in the last quarter. Finally, World Investment Advisors LLC purchased a new position in Milestone Scientific during the 3rd quarter valued at about $91,000. Hedge funds and other institutional investors own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
